Illustrative image – not actual.
The Telangana government has announced that six leading pharmaceutical companies, including Dr Reddy's Laboratories, Aurobindo Pharma, Hetero Labs, and MSN Laboratories, have signed memorandums of understanding (MoUs) to establish facilities in the state’s upcoming Pharma City.
This strategic move involves an investment of over Rs 5,260 crore, projected to create employment for 12,490 persons in the pharmaceutical sector. Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu finalised the agreements during a meeting with representatives of the companies at the Secretariat.
The government has assured the allocation of land and provision of essential infrastructure to support these ventures, with construction expected to commence within four months. MSN Laboratories will set up a manufacturing unit and R&D centre, Laurus Labs and Aurobindo Pharma will establish formulation units, and Gland Pharma will develop an R&D centre along with facilities for injectables and drug substance manufacturing.
Dr Reddy's Laboratories will focus on injectable and biosimilar production, while Hetero Labs will establish a finished dose and injectable manufacturing plant. This development aligns with the efforts to position the state as a hub for pharmaceutical innovation and manufacturing, leveraging Pharma City’s infrastructure to attract significant investments.
